Ligand profile
ZINC3334151
Virtual-screening candidate from ZINC.
Bound to: KP13_00203 — putative 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate coenzyme A ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC3334151- UniProt (similar protein)
P22557- Tanimoto
- 0.806
- Target protein
- KP13_00203
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 42.0
- −1 ≤ LogP ≤ 5 2.05
- MW ≤ 500 Da 226.3
- LogP ≤ 5 2.05
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 42.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(NCCc1ccccc1)c1ccccn1O=C(NCCc1ccccc1)c1ccccn1
InChI=1S/C14H14N2O/c17-14(13-8-4-5-10-15-13)16-11-9-12-6-2-1-3-7-12/h1-8,10H,9,11H2,(H,16,17)InChI=1S/C14H14N2O/c17-14(13-8-4-5-10-15-13)16-11-9-12-6-2-1-3-7-12/h1-8,10H,9,11H2,(H,16,17)
RJIWORZDUGBXNH-UHFFFAOYSA-NRJIWORZDUGBXNH-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- NUM
- Homolog
- P22557
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC3334151 →
- ZINC ZINC20 ZINC3334151 →
- UniProt UniProt P22557 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC3334151”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00203.
PDB 33
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).